| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 03/30/2006 | US20060069100 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity |
| 03/30/2006 | US20060069084 Methods of inhibiting kinases |
| 03/30/2006 | CA2580238A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |
| 03/29/2006 | EP1640402A1 Diamine having quinoxaline unit, polyimide precursor, polyimide and use thereof |
| 03/29/2006 | EP1638956A1 2,3-substituted 5,6-diaryl-pyrazine derivatives as cb1 modulators |
| 03/29/2006 | EP1638953A1 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators |
| 03/29/2006 | EP1638945A1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents |
| 03/29/2006 | EP1638551A2 Immunosuppressant compounds and compositions |
| 03/29/2006 | EP1492792B1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino¬4,5-b|indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 03/29/2006 | CN1753849A Mono amine and diamine derivatives of cl-20 |
| 03/29/2006 | CN1247587C Tert. alkylphenoxy substituted polycyclic compounds |
| 03/29/2006 | CN1247574C Isoindolin-1-one glucokinase activators |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/28/2006 | US7019129 at least three radicals selected from substituted or unsubstituted aryl, heteroaryl and combinations, wherein at least two of the residues are covalently linked via an exocyclic diazo bond, and a reactive functional group providing a locus for conjugation of the quencher to a carrier |
| 03/28/2006 | US7019011 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | CA2125104C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/28/2006 | CA2120374C 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 03/23/2006 | WO2006030208A1 Amino acid |
| 03/23/2006 | WO2006030032A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 03/23/2006 | WO2006029906A1 Methylene dipiperidine derivatives |
| 03/23/2006 | US20060063789 Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors |
| 03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 03/23/2006 | US20060063780 Sodium channel blockers |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060062932 has optical properties with films that are significantly thinner |
| 03/23/2006 | CA2581144A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 03/23/2006 | CA2579847A1 Bicyclic anilide spirolactam cgrp receptor antagonists |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | CN1751046A Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments |
| 03/22/2006 | CN1751024A Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same |
| 03/21/2006 | US7015325 Alkyne oxy carbamate derivatives used to treat respiratory system disorders |
| 03/21/2006 | US7015323 Resistant to metabolism having improved half-life and/or clearance properties compared to corresponding carbamate compounds; for example, N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; use to treat inflammatory diseases for example |
| 03/21/2006 | US7015227 Amino -benzenes, -pyridines, -pyrimidines, -pyrazines, -pyridazines, -pyrazoles; anticancer agents |
| 03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
| 03/21/2006 | CA2242416C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 03/16/2006 | WO2006027348A1 Phenylaminopyridines |
| 03/16/2006 | WO2006027252A1 Sigma receptor ligands |
| 03/16/2006 | US20060058524 coupling aromatic or heteroaromatic halogen compounds to form one or more C C single bonds, characterized in that an Ni(0) complex comprising at least two different ligands |
| 03/16/2006 | US20060058315 2-Oxo-ethanesulfonamide derivates |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058178 Aromatic compounds containing nitrogen and p- functionalized amines, the production thereof and their use in catalytic reactions |
| 03/16/2006 | CA2577610A1 Sigma receptor ligands |
| 03/15/2006 | EP1633729A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 03/15/2006 | CN1747955A Nitrogen-substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments |
| 03/15/2006 | CN1747929A Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 03/15/2006 | CN1245391C Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |
| 03/15/2006 | CN1245161C A method of modulating ion channel functional activity |
| 03/14/2006 | US7012077 Anticholesterol agents; antilipemic agents |
| 03/14/2006 | CA2289987C Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia |
| 03/09/2006 | WO2006024523A1 Phthalamide derivatives for use as insecticides |
| 03/09/2006 | WO2005097751A3 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands |
| 03/09/2006 | US20060052627 Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 03/09/2006 | US20060052597 Aryloxyalkylamine derivatives as h3 receptor ligands |
| 03/09/2006 | US20060052445 Diarylsulfones as 5-HT2A antagonists |
| 03/09/2006 | US20060052396 Arylamines for the treatment of conditions associated with gsk-3 |
| 03/09/2006 | US20060052395 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 03/09/2006 | US20060052394 N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; hydrates mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life; skin and respiratory disorders, vision deffects |
| 03/09/2006 | US20060052393 Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase |
| 03/09/2006 | US20060051879 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 03/09/2006 | CA2577398A1 Urea derivatives as calcium channel blockers |
| 03/09/2006 | CA2576830A1 Arylamine ketones, their preparation methods, the pharmaceutical compositions containing them and their use |
| 03/08/2006 | EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 03/08/2006 | EP1632477A1 Benzamide derivative or salt thereof |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1325009B1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| 03/08/2006 | CN1745074A 5-HT receptor ligands and uses thereof |
| 03/08/2006 | CN1743330A Aspergillus fumigatus dardarin C analogue, and its synthesizing method and use |
| 03/08/2006 | CN1743329A Hexahydro-pyrazino-pyridino-indole dione, and its synthesis and use |
| 03/08/2006 | CN1743328A Hexahydro-pyrazino-pyridino-indole, and its systhesis and use |
| 03/08/2006 | CN1244584C Synthesis method of triethylene diamine from piperazine byproduct |
| 03/08/2006 | CN1244565C New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 03/08/2006 | CN1244542C Aromatic amine derivatives having NOS inhibitory effect |
| 03/08/2006 | CN1244536C Aroxyphenoxy carboxylic acid ester compounds with herbicidal activity |
| 03/07/2006 | US7008945 Amide derivatives |
| 03/02/2006 | WO2006023849A2 Catalysis of diketopiperazine synthesis |
| 03/02/2006 | WO2006021806A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
| 03/02/2006 | WO2006021805A1 Diarylsulfones as 5-ht2a antagonists |
| 03/02/2006 | WO2005113542A3 N-cyclic sulfonamido inhibitors of gamma secretase |
| 03/02/2006 | US20060046991 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors |
| 03/02/2006 | CA2578283A1 Heterocyclic compounds and methods of use |
| 03/02/2006 | CA2578075A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors |
| 03/02/2006 | CA2577837A1 Diarylsulfones as 5-ht2a antagonists |
| 03/02/2006 | CA2575692A1 Catalysis of diketopiperazine synthesis |
| 03/02/2006 | CA2575680A1 Cyclic amide & ester pyrazinoylguanidine sodium channel blockers |
| 03/02/2006 | CA2575670A1 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 03/02/2006 | CA2575645A1 Soluble amide & ester pyrazinoylguanidine sodium channel blockers |
| 03/01/2006 | EP1628661A2 Modulators of vr1 receptor |
| 03/01/2006 | EP1345942B1 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists |
| 03/01/2006 | CN1742001A Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands |
| 03/01/2006 | CN1741996A Carboxamide derivatives and their use as factor XA inhibitors |
| 03/01/2006 | CN1741990A Arylalkylcarbamate derivatives production and use thereof in therapy |
| 03/01/2006 | CN1243753C Substituted 3,4-dihydro-pyrimido[1,2-A] pyrimidines and 3,4-dihydropyrazino [1,2-A] pyrimidines |
| 02/28/2006 | US7005440 Therapeutic uses of tri-aryl acid derivatives |
| 02/28/2006 | US7005436 Heterocyclo inhibitors of potassium channel function |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/23/2006 | WO2006021002A2 Compounds useful for inhibiting chk1 |
| 02/23/2006 | US20060041133 Catalysis of diketopiperazine synthesis |
| 02/23/2006 | US20060040953 dry powder therapeutic agent containing an aniton selected from 3,6-di(succinate-4-aminobutyl)-2,5-diketopiperazine, 3,6-di(fumarate-4-aminobutyl)-2,5-diketopiperazine; cation is selected from Na, K, Ca, Li, triethylamine, butylamine, diethanolamine and triethanolamine; and a drug; dry powder |